Clinical Trial

The DRAGON 2 Trial

Study acronym: DRAGON 2
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 1, 2024 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
In the randomized controlled DRAGON 2 trial study subjects will be randomized between two arms, PVE alone (control group) and PVE/HVE (interventional group).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-06-17; most recent amendment 2024-10-29.
Status change: Not Yet Recruiting → Recruiting 2023-05-23
Trial Details
NCT Number NCT05428735
Lead Sponsor Maastricht University
Conditions Colorectal Cancer Liver Metastases (CRLM), Small Future Liver Remnant (FLR)
Enrollment 348 participants
Start Date 2022-04-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-01